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Abstract: This essay examines how repugnance sometimes constrains what transactions
and markets we see. When my colleagues and I have helped design markets and
allocation procedures, we have often found that distaste for certain kinds of transactions
is a real constraint, every bit as real as the constraints imposed by technology or by the
requirements of incentives and efficiency.  I’ll first consider a range of examples, from
slavery and indentured servitude (which once were not as repugnant as they now are) to
lending money for interest (which used to be widely repugnant and is now not), and from
bans on eating horse meat in California to bans on dwarf tossing in France.  An example
of special interest will be the widespread laws against the buying and selling of organs
for transplantation. The historical record suggests that while repugnance can change over
time, it can persist for a very long time, although changes in institutions that reflect
repugnance can occur relatively quickly when the underlying repugnance changes.2
Why can’t you eat horse or dog meat in a restaurant in California, a state with a
population that hails from all over the world, including some places where such meals are
appreciated? The answer is that many Californians not only don’t wish to eat horses or
dogs themselves, but find it repugnant that anyone else should do so, and they enacted
this repugnance into California law by referendum in 1998. Section 598 of the California
Penal Code states in part: “[H]orsemeat may not be offered for sale for human
consumption. No restaurant, cafe, or other public eating place may offer horsemeat for
human consumption.”  The measure passed by a margin of 60 to 40 percent with over 4.6
million people voting for it (see <http://vote98.ss.ca.gov/Returns/prop/00.htm>.
Notice that this law does not seek to protect the safety of consumers by governing the
slaughter, sale, preparation and labeling of animals used for food. It is different from laws
prohibiting the inhumane treatment of animals, like rules on how farm animals can be
raised or slaughtered, or laws prohibiting cockfights, or the recently established (and still
contested) ban on selling foie gras in Chicago restaurants (Ruethling, 2006). It is not
illegal in California to kill horses; the California law only outlaws such killing “if that
person knows or should have known that any part of that horse will be used for human
consumption.”  The prohibited use is “human consumption,” so it apparently remains
legal in California to buy and sell pet food that contains horse meat (although the use of
horse meat in pet food has declined in the face of the demand for U.S. horse meat in
Europe, for human consumption).
The repugnance of eating horses is not limited to California. On September 7, 2006, the
U.S. House of Representatives passed, by a vote of 351 – 40, and sent to the Senate, H.R.
503: “To … prohibit the shipping, transporting, moving, delivering, receiving,
possessing, purchasing, selling, or donation of horses and other equines to be slaughtered
for human consumption.” (That bill seems unlikely to pass into law, however.)
Apparently, some kinds of transactions are repugnant in some times and places and not in
others.  This essay examines repugnance and its consequences for what transactions and
markets we see. When my colleagues and I have helped design markets and allocation
procedures, we have often found that distaste for certain kinds of transactions can be a
real constraint on markets and how they are designed, every bit as real as the constraints
imposed by technology or by the requirements of incentives and efficiency. In this essay
I’ll first consider a wide range of examples, including slavery and indentured servitude,
lending money for interest, price-gouging after disasters, selling pollution permits and
life insurance, and dwarf tossing.
This will bring me naturally to the laws against the buying and selling of kidneys for
transplantation, which will connect this essay with the others on organ transplantation in
this issue. Because healthy people have two kidneys and can remain healthy with only
one, kidneys from living donors are now widely used for kidney transplantation, the
preferred treatment for end stage renal disease.  The laws against buying or selling
kidneys reflect a reasonably widespread repugnance, and this repugnance may make it
difficult for arguments that focus only on the gains from trade to make headway in
changing these laws.3
That does not mean that no gains from exchange can be realized, in fact some gains are
beginning to be realized in the kidney exchange programs that Tayfun Sönmez and Utku
Ünver and I have helped to design in New England and elsewhere.  In the simplest form
of kidney exchange, a patient with a willing donor who has an incompatible blood type
(or who is incompatible for another reason) can exchange a kidney with another such
incompatible patient-donor pair. (That is, the pairs are matched so that the donor from
one pair is compatible with the patient from the other, and each patient receives a kidney
from the other patient’s donor.) This sort of “in kind” exchange has gained acceptance in
the transplant community.
1
More generally, this essay will explain why I think economists need to understand better and
engage more with the phenomenon of repugnant transactions. Attitudes about the repugnance
or other kinds of inappropriateness of transactions shape whole markets, and therefore shape
what choices people face.
Repugnant Markets
Table 1 lists some examples of transactions in which repugnance has established
important constraints, presently or at some time in the past. The arrow of time points in
both directions: some markets that are repugnant today once were not (or not sufficiently
to serve as a binding constraint).  Other markets are not widely repugnant today that once
were.
[Table 1 about here]
Slavery is an obvious example of a market that is now repugnant and illegal even
in places like the United States where such markets were once openly conducted.
 Slavery
was forbidden by the 13
th amendment to the U.S. Constitution in 1865, which states:
“Neither slavery nor involuntary servitude, except as a punishment for crime whereof the
party shall have been duly convicted, shall exist within the United States, or any place
subject to their jurisdiction.” Courts have interpreted this amendment as also outlawing
indentured servitude, and today we find servitude so repugnant that a person may not
even sell him or her self into slavery or indentured servitude. But indentured servitude
was once one of the common ways for Europeans to buy passage across the Atlantic to
America (Galenson, 1981).
Lending money for interest was once widely repugnant, and no longer is, (with the
important exception that Islamic law is commonly interpreted as prohibiting it). State
usury laws in the United States, and Islamic banks in some countries, are examples of
                                                   
1 See Roth, Sonmez, and Unver (2004, 2005a,b, 2007), Saidman, Roth, Sonmez, Unver, and Delmonico
(2006), and Roth, Sonmez, Unver, Delmonico, and Saidman (2006) for discussions of the issues involved
in organizing kidney exchange on an efficient scale.  A very small number of individual kidney exchanges
had been conducted before the issue of efficient organization was raised, giving an early indication that this
kind of exchange did not arouse the repugnance associated with monetary payments for organs.4
modern expressions of this repugnance.
2   The changing repugnance of debt and of
involuntary servitude have even interacted, in changes in bankruptcy law. In colonial
America and the early years of the Republic, insolvent debtors could be imprisoned, or
sentenced to indentured servitude (Coleman, 1974). But as involuntary servitude became
more repugnant, and debts less repugnant, bankruptcy laws were rewritten to be less
punitive to debtors.
The examples in Table 1, and others I will discuss, reflect that, even when there may be
willing suppliers and demanders of certain transactions, aversion to those transactions by
others may constrain or even prevent them.  In Table 1, “repugnance” or even “revulsion”
is often exactly the right word for how some transactions are or were once regarded.  In
other examples, a milder word would be more apt: some transactions may be called
distasteful, inappropriate, unfair, undignified, or unprofessional.
Of course, there may also be other reasons to object to markets that some people find
repugnant, and so it may be difficult to attribute only to repugnance the limits on certain
markets.  For example, while hiring mercenaries was once an accepted way of dealing
with military affairs (and although there has once again been increasing use of private
security firms to perform defensive military functions), mercenaries have largely fallen
out of favor. The declining use of mercenaries is not only because of repugnance towards
the fact that mercenaries kill for pay rather than for state-sanctioned duty or patriotism.
But that such repugnance plays a role is strongly suggested by the lesser protection
mercenaries receive under international law. For example, Article 47 of the Protocol
Additional to the Geneva Conventions of 12 August 1949, and relating to the Protection
of Victims of International Armed Conflicts   states: “A mercenary shall not have the
right to be a combatant or a prisoner of war.”
How Repugnance Combines With Other Factors
Some markets are banned or limited for combinations of reasons that include both
repugnance and also concerns about negative externalities. For example, limits on
prostitution or pornography depend in part on revulsion at commercializing sex. Fiske
and Tetlock (1997) talk about “taboo tradeoffs between different spheres of justice” to
discuss why bringing to the market activities or goods that are customarily provided in
other settings, like within families, may seem inappropriate or worse.  But concern also
arises about the negative effects pornography or commercial sex may have on the quality
                                                   
2  Near the beginning of his essay “The Spirit of Capitalism,” Max Weber quotes Benjamin Franklin on the
virtues of responsible lending and borrowing, and near the end of the essay Weber (1930, p. 74) asks
“Now, how could activity, which was at best ethically tolerated, turn into a calling in the sense of Benjamin
Franklin?”  Hirschman (1977, p. 9)  paraphrases Weber’s question as “How did commercial, banking, and
similar money-making pursuits become honorable at some point in the modern age after having stood
condemned or despised as greed, love of lucre, and avarice for centuries past?” In this journal, see Persky
(2007) on the Jeremy Bentham/Adam Smith arguments about usury, and Kuran (1995) on Islamic banks.5
of life in neighborhoods where it is sold.  In addition, prostitution and pornography may
not involve only transactions between willing parties.
Bans on commerce involving material judged to be obscene may also involve concerns
about externalities, as in Federal Communications Commission regulations regarding
certain words forbidden on radio and television broadcasts, or voluntary regulations
concerning whether children can see certain movies; for example, Fairman (2007)
discusses the laws and jurisprudence concerning the word “fuck.” But repugnance can be
present even when externalities are minimal. For example, in 1959 the U.S. Post Office
imposed a ban on sending copies of D.H. Lawrence’s Lady Chatterley’s Lover through
the mail (this story and several related obscenity trials are recounted in Rembar, 1968).
Similarly, bans in various times and places on profane language may primarily concern
externalities, but bans on blasphemy—like banning the sale of Salman Rushdie’s Satanic
Verses in a number of Islamic countries--seem also to be aimed at limiting private
consumption (and production).
Limits on the sale of alcohol and various drugs, and on gambling, may also be
complicated in this way. (The sale of alcohol was banned throughout the United States
from 1920 to 1933 by the 18th amendment to the Constitution, known as “Prohibition,”
which was repealed by the 21st amendment, although individual states and counties still
retain a variety of restrictions.)   When addiction is an issue, even apart from the negative
externality imposed on third parties (through increases in bankruptcy and crime, for
example), we may question whether the parties to the transaction are willing in the sense
that economists normally mean when we discuss voluntary transactions.
Some kinds of repugnance are also intermixed with concerns about providing incentives
for bad behavior.   The very idea of life insurance (“You want to set a price on your life,
and then place a bet on your date of death?”) seems to have had to overcome initial
repugnance in the early 1800s (Zelizer, 1979). The incentive issue was often addressed
by “insurable interest” laws specifying who could be a beneficiary of life insurance. As
discussed by Justice Oliver Wendell Holmes Jr. in a 1911 Supreme Court case: “A
contract of insurance upon a life in which the insured has no interest is a pure wager that
gives the insured a sinister counter interest in having the life come to an end.” [Grigsby v.
Russell, 222 U.S. 149 (1911) , 222 U.S. 149, Decided December 4, 1911]. Even today,
life insurance for small children raises questions about motives.  The insurance industry
lobbies against Stranger (or Investor) Owned Life Insurance (SOLI) and “viatical
settlements,” which are third party markets and funds that purchase life insurance policies
from elderly or terminally ill patients who wish to realize the cash value of their policies
while still alive.  The arguments against such funds often focus on the repugnance of
having life insurance held by an entity that profits from deaths (in contrast to insurance
companies, which make money when their customers continue living). Of course, sellers
of annuities also profit from untimely deaths. For some flavor of the discussions about
these issues, see Silverman (2005).
Repugnance to betting on life and death also shows up in other contexts.  In July 2003, a
proposed U.S. government-funded “prediction market” for terrorism-related events was6
scrapped amidst much publicity, with the Senate Minority Leader (Tom Daschle) saying
“I can't believe that anybody would seriously propose that we trade in death.” Senator
Barbara Boxer was quoted as saying “There is something very sick about it," and adding
that those responsible should be fired. In this discussion, there was also some concern
that terrorists themselves shouldn’t be encouraged to play such markets (CNN.com,
2003).
To clarify ideas about repugnance, it may be helpful to look at a relatively uncomplicated
case, in which little else besides repugnance seems to be at work.  Dwarf tossing seems
like a market whose widespread banning involves no more than simple repugnance.
Dwarf Tossing
Dwarf tossing is an activity in which a large person throws a small person.  The venue
often is one in which alcohol is served. It is often a source of livelihood for the small
person, with the large person paying for the privilege.  While legal in many places,
dwarf-tossing is sometimes banned by law. These bans suggest a concern quite different
from occupational health and safety regulations that might attempt to regulate how to
conduct such an event (for instance,  by requiring the wearing of helmets and kneepads).
For example, the summary of the Ontario Dwarf Tossing Ban Act of 2003 states: “The
Bill bans dwarf tossing in Ontario and makes it an offence to engage in dwarf tossing.”
The matter came before the UN Human Rights Committee after the French Ministry of
the Interior, in 1991, issued a statement saying that “dwarf tossing should be banned on
the basis of, among other things, article 3 of the European Convention for the Protection
of Human Rights and Fundamental Freedoms.” After bans were subsequently enforced in
some municipalities, a French dwarf, who had been employed by a company called
Société Fun-Productions, successfully sued in French courts to have the bans overturned.
However the bans were upheld on appeal in 1995 by the French Council of State on the
grounds that “dwarf tossing… affronted human dignity.” The dwarf then brought his
complaint to the United Nations, asserting that he was the victim of a discriminatory
violation by France of his right to employment. A report from the Office of the United
Nations High Commissioner for Human Rights (2002) further notes that he stated “that
there is no work for dwarves in France and that his job does not constitute an affront to
human dignity since dignity consists in having a job.”  However the UN committee found
in favor of France: “The Committee considers that [France] has demonstrated…that the
ban on dwarf tossing… did not constitute an abusive measure but was necessary in order
to protect public order, which brings into play considerations of human dignity that are
compatible with the objectives of the Covenant.”  Thus the UN committee, like the
French Council of State, essentially concluded that dwarf tossing was itself so repugnant
that it imposed a negative externality by diminishing human dignity, a public good.
Repugnance Is Hard To Predict
Repugnance, whether alone or in alliance with other objections, can impose serious
constraints on various kinds of transactions.  However, predicting when repugnance will7
play a decisive role is difficult, because apparently similar activities and transactions are
often judged differently.  For example, while dwarf tossing is repugnant in many places,
wife carrying, another sport that involves persons of disparate stature, has North
American and world championships. In wife carrying, large men carrying small women
(not necessarily their wives) race to complete an obstacle course in the fastest time, with
the prize traditionally including the “wife’s” weight in beer. The website of the world
championship in Finland is at <http://www.sonkajarvi.fi/?deptid=15136>.
Many other examples of apparently similar activities elicited very different reactions
regarding their repugnance.
The proposed prediction market for terrorist events met with vigorous denunciation, but
general prediction markets have thrived, including some that include bets on various
aspects of current events, as discussed by Wolfers and Zitsewitz ( 2004) in this journal.
In 1990, the Clean Air Act was amended to allow trading of rights to pollute through
tradable emissions entitlements. In 1991, the World Bank issued a memo under the
signature of its then-chief economist Lawrence Summers,  suggesting that it would be
efficient for polluting industries to be located in low-income countries. Both policies
involve relocating pollution. But although some critics found “selling a right to pollute”
to be repugnant, the 1990 law passed as an efficiency-enhancing measure with relatively
little public controversy (Schmalensee et al., 1998). However, the World Bank memo set
off a firestorm of public controversy (Harvard Magazine, 2001). Similar controversies
have erupted around issues such as whether New York City can send its garbage to
landfills in other states.
There are laws criminalizing kickbacks offered by vendors to purchasing agents, and
such behavior is viewed with repugnance. However, no legal and few corporate
restrictions exist on frequent flier miles given to business travelers, who book their flights
in their capacity as purchasing agents for their companies. Frequent flyer miles are not
viewed as a repugnant kickback, but as an appropriate reward.
There are laws against various forms of “price gouging,” and ticket scalping remains
illegal in many places. However, Ticketmaster has recently started auctioning some
tickets just before the time of the event (Smith and Silver, 2006).
Payment to the birth mother for a child genetically related to the mother is widely
regarded as repugnant, and forbidden both internationally by the Hague Convention on
Intercountry Adoption, and in the United States though the Intercountry Adoption Act of
2000.  However, largely unregulated markets have developed for many relatively new
forms of reproductive technology, from markets for sperm and eggs, to the hiring of
surrogate mothers who have a fertilized egg implanted and carry out the pregnancy of a
genetically unrelated child (Spar, 2006).
Finally, the sale of food crops that have been modified by traditional methods of cross
breeding do not seem widely repugnant anywhere. However, food crops genetically8
modified by recombinant DNA technology are not accepted nearly as widely. See, for
example, the European Union’s wide array of regulations limiting genetically modified
crops, listed at <http://ec.europa.eu/food/food/biotechnology/gmfood/legisl_en.htm>.
Cash Payments and Repugnance
One often-noted regularity is that some transactions that are not repugnant as gifts and in-
kind exchanges become repugnant when money is added. The historical repugnance to
charging interest for loans seems to fall into this class, as do prohibitions on paying birth
mothers of children put up for adoption, and perhaps prostitution. That is, loans
themselves, and adoption, and love are widely regarded as good things when given freely,
even when their commercial counterparts are regarded in a negative way. Similarly, in
Massachusetts and California, it is legal to sell human eggs for fertilization but illegal to
sell them for research purposes, although it is legal to donate them for research
(Associated Press, January 20, 2007). And widespread outrage in Britain greeted the
decision to allow sailors recently released from captivity in Iran to sell their stories to
news media: after two sailors had done so, the remaining sailors were no longer allowed
to receive money for interviews (Peck, 2007).
Offering money is often regarded as inappropriate even when not repugnant. For
example, dinner guests at your home may respond in-kind, by bringing wine or inviting
you to dinner in return, but they would likely not be invited back if they offered to pay
for their dinner. Sometimes the level of the price is regarded as repugnant rather than the
existence of a price: after a natural disaster it is often regarded as acceptable to sell
supplies at their pre-disaster price, but as repugnant price-gouging to raise the price (see
for example Kahneman, Knetsch, and Thaler, 1986). Also, there may be resistance to
charging for goods that have previously been provided for free or at low cost: like water
or the right to drive in cities during rush hours.
Of course, sometimes laws or public outrage focus on monetary transactions only
because they are easier to ban than non-monetary transactions.  For example, the
supporters of the law that forbids restaurants from selling horsemeat in California aren’t
trying to preserve the sanctity of the family barbecue; they find eating horses repugnant,
but regulation of restaurants was easier than passing laws about what could be cooked at
home.
Concerns about the monetization of transactions fall into three principal classes.  One
concern is objectification: that is, the fear that putting a price on certain things and
buying or selling them might move them into a class of impersonal objects to which they
should not belong. The sociology literature has shown a longstanding interest in how the
introduction of money changes many kinds of social relationships and their meanings (as
a starting point, see Simmel, 1990).  A second concern is that offering substantial
monetary payments might be coercive, in the sense that it might leave some people,
particularly the poor, open to exploitation from which they deserve protection. A third9
concern, sometimes less clearly articulated, is that monetizing certain transactions that
might not themselves be objectionable may cause society to slide down a slippery slope
to genuinely repugnant transactions. Let’s consider these three concerns in more detail as
they apply to paying organ donors.
Compensating Organ Donors
Objectification
Many people clearly regard monetary compensation for organ donation as something that
transforms a good deed into a bad one.  In both western Europe and the United States,
governments strongly encourage organ donation, but forbid monetary payments to donors
or their heirs. For example, Article 21 of the Council of Europe’s (2002) Additional
Protocol to the Convention on Human Rights and Biomedicine, on Transplantation of
Organs and Tissues of Human Origin states: “The human body and its parts shall not, as
such, give rise to financial gain.” However, the European legislation does exempt from
this prohibition compensation to donors for expenses and loss of earnings.   The U.S.
National Organ Transplant Act of 1984 states “it shall be unlawful for any person to
knowingly acquire, receive or otherwise transfer any human organ for valuable
consideration for use in human transplantation.” This law also exempts payment of
expenses directly incurred by organ donors, like travel expenses.
The feeling that virtuous organ donations are transformed into immoral commercial
transactions by the introduction of monetary payments is clearly enunciated in the
writings and speeches of Pope John Paul II.  In his 1998 encyclical letter Evangelium
Vitae (paragraph 86), the Pope mentions the donation of organs as a “particularly
praiseworthy example” of an action that builds “an authentic culture of life.” But in an
address to transplant surgeons in Rome, John Paul (2000) warned that “any procedure
which tends to commercialize human organs or to consider them as items of exchange or
trade must be considered morally unacceptable, because to use the body as an "object" is
to violate the dignity of the human person.”  The Lutheran Church in America (1984)
expresses a similar sentiment.
I note in passing that other religious traditions view the matter very differently.  The
emerging Jewish consensus on live kidney donations, for example, is that donation of
organs is a good thing, and that under some circumstances it would be allowable to offer
and accept compensation.
 3 This opinion reflects the tremendous importance that Jewish
law gives to saving a life, which can overturn many more mundane prohibitions. For
                                                   
3 While there is no central authority on the application of Jewish law to modern concerns such as
transplantation, the most authoritative opinions are contained in various “responsa” or answers to particular
questions by rabbis acting as legal “deciders” (poskim), whose authority arises from the respect of their
peers.  The consensus on the matter of live kidney donation, for example, seems to be that live donation is
allowed (since it saves lives), but it is not required (since the donor becomes wounded and takes some risk
to his own life), and hence it falls into the category of things for which compensation could be offered and
accepted (unlike actions that are either forbidden or required). See e.g. Eisenberg (2006), Grazi and
Wowlowelsky (2004), Kunin (2005), and Israeli (1997) who cite eminent modern poskim such as R.
Shlomo Zalman Auerbach and R. Moshe Feinstein..10
example, Avraham (2004, p. 271-2) reports the opinion of the eminent Rabbi Shlomo
Zalman Auerbach that someone who sells a kidney with the intention of saving a life
does a good deed “even if he would not have donated his kidney only to save life.” But
he goes on to note, “[I]n spite of all that has been said above, it seems to me that it is the
community that needs soul-searching for allowing a person to reach such a depth of
despair that he must sell a kidney, either because of poverty, debts or the inability to pay
for a relative’s medical expenses.”
I am less familiar with Islamic thought on the matter, but I surmise that it is in some
respects similar, since the Islamic Republic of Iran presently allows live kidney donors to
receive monetary payments (Bagheri, 2006; Ghods and Savaj, 2006).
Coercion
A different concern, quite common in the organ transplant literature and
elsewhere, is that money may be coercive, so that allowing kidneys to be sold would
allow the poor to be exploited.  Even in the absence of money, transplant surgeons are
eager to avoid accepting organs from donors who may feel coerced, perhaps by family
pressure. Contract law in general holds that contracts may be voidable by the courts in
case of coercion due to, among other things, “undue influence” by parties with special
relationships (Farnsworth, 1990, section 4.20). (I am not aware, however, of any part of
contract law that views excessive monetary compensation as a source of coercion.)
Interestingly, Ghods and Savaj (2006) express the view that the availability of paid
unrelated kidney donors in Iran has reduced the coercion of unpaid related donors.
In a recent exchange, Gaston et al. (2006) proposed in the American Journal of
Transplantation that it might be possible to avoid the repugnance of outright payments
for kidneys, while “limiting financial disincentives in live organ donation,” by providing
a fixed package of benefits to kidney donors, including insurance, compensation for
expenses and lost wages, and a fixed payment (they suggest $5,000) to compensate
donors for pain and suffering.  In response, in an editorial in the same issue of the journal,
Fox (2006) writes of the “moral cost of living donor inducements.” Fox argues: “While
the proposed benefit may not be a deciding factor to the CEO of a Fortune 500 company,
to someone earning only minimum wage, the compensation may represent several
months’ pay. To deny the potential of this proposal to ‘coerce an otherwise unwarranted
decision to donate’ reflects the folly of the privileged, not the reality of the poor.”
Similarly, Kahn and Delmonico (2004) summarize their opposition to buying and selling
organs by saying: “It is an unethical approach to shift the tragedy from those waiting for
organs to those exploited into selling them.”
This viewpoint is not restricted to the transplant community. The National Bioethics
Advisory Commission (2001), writes that paying subjects to participate in medical
experiments may be coercive.
4 They go on to say that, if an institutional review board is
                                                   
4 In contrast, experimental economists often think that paying subjects in economic experiments, based on
their performance, is an essential element in creating an economic environment in the laboratory  in which
the experimenter can exercise some control over subjects’ preferences .11
concerned that the subjects in an experiment may be economically disadvantaged, it may
require that the researchers reduce the payments they make to participants. The concern
here is not to protect the research design against the possibility that rich and poor
participants might self-select differently into the experiment for a given participation fee,
but rather to protect low-income participants from being faced with such a high
participation fee that they would feel coerced to participate. Baron, (2006) offers a
critical view of this line of argument.
Slippery slope
Concern that monetizing some transactions might lead to other changes seems to lurk
beneath the more explicit concerns.  Some critics fear a commercial dystopia in which
kidney sales would enter into contracts: for example, as collateral, or as payment for
other medical services, or to repay debts, or as means tests for eligibility for social
services and financial aid. Such scenarios have found their way into fiction and movies
also (Ishiguro, 2005; Picoult, 2004; Farmer, 2002).
This concern is not altogether different from concerns about how legalizing certain kinds
of voluntary transactions may change the terms of trade so as to disadvantage those who
don’t wish to participate in them.  In this journal, Basu (2003) uses sexual harassment as
an example, and argues that legalizing labor contracts that allowed sexual harassment
would put workers who did not wish to be party to such contracts at a disadvantage
relative to the status quo in which such contracts are illegal.  Similarly, for example, bans
on polygamy might be understood as outlawing certain kinds of competition that would
disadvantage some men and some women relative to the monogamous status quo, even
while allowing others to engage in welfare-improving transactions.
Some (but by no means all) of the opposition to monetary compensation for deceased
donor organs seems also to be of the slippery slope variety, with the concern being that it
might pave the way for live organ sales.
Accounts of black markets for kidney transplants lead to concerns about whether legal
markets would inevitably be similar.  In this connection, Schepper-Hughes (2003, p.
1645) summarizes the black market experience as follows.  “In general, the circulation of
kidneys follows established routes of capital from South to North, from East to West,
from poorer to more affluent bodies, from black and brown bodies to white ones, and
from female to male or from poor, low status men to more affluent men.” She concludes
(p. 1648): “The division of the world into organ buyers and organ sellers is a medical,
social, and moral tragedy of immense and not yet fully recognized proportions.”
A related concern is that monetary markets might crowd out altruistic giving, and that
this might both reduce the supply of transplantable kidneys (Howard, this issue; Institute
of Medicine, 2006) and harm other characteristics of the organ transplantation process --
for example, Danovitch and Leichtman (2006) worry that it could reduce the incidence of
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deceased donation, which supplies not only kidneys but other organs as well). A related
literature in economics and psychology is concerned with the loss of intrinsic motivation
that might accompany the introduction of monetary payments (for example, Gneezy and
Rustichini, 2000).
The medical literature encompasses broad views on these subjects and also contains
arguments in reply.  For example Hippen (2005) notes that regulated legal markets might
be quite different from illegal ones, and that similar slippery slope fears were expressed
about allowing live kidney donations from unrelated donors, but that unrelated donors are
now a substantial percentage of all donors. Matas and Schnitzler (2004) argue that
allowing kidney sales would be socially cost effective (Matas is the current president of
the American Society of Transplant Surgeons).
Other Sources of Repugnance Towards Paying For Live Donor Kidneys
Although I have argued that repugnance felt towards kidney sales shares characteristics with
repugnance towards monetizing other kinds of transactions, payments for live kidney donors
may also have some unique features.
For example, taking a kidney from a healthy donor holds little appeal to surgeons trained in
the Hippocratic tradition of “first, do no harm.”  While live donor kidney transplants save
lives, it is not the life of the donor that is being saved. A surgeon who is already overcoming
some distaste for performing a nephrectomy (kidney removal) on a healthy person may find
the distaste more difficult to overcome if he views himself as facilitating a commercial
transaction. However surgeons may not (or may no longer) be the primary locus of
repugnance to kidney sales. In an informal poll following a debate on the subject at a recent
meeting of the American Society of Transplant Surgeons, a majority of those polled
expressed a willingness to contemplate a trial or demonstration project (personal
communication, Arthur Matas, 1/27/07).
Overall, Boulware et al. (2006) report on the basis of a telephone survey of randomly
selected households: “The U.S. public is not generally supportive of incentives for DD
[deceased organ donation], but is supportive of limited incentives for LD [live donation].
Racial/ethnic minorities are more supportive than Whites of some incentives. Persons with
low income may be more accepting of certain monetary incentives.”
Historical Perspective
To put the debate about organ donation into some historical context, consider the
case of cadavers.  When the British medical journal The Lancet published its first volume
in 1824, its pages reflected a concern that too few cadavers were available for anatomy
classes. The main source of cadavers was an illegal black market supplied by so-called
“resurrection men,” and an editorial by that name opens with the news that a reliable
resurrection man had recently been arrested and sentenced.  The editorial goes on to
suggest—in an early observation that how issues are framed may influence how they are
perceived--that the government policy of only allowing the bodies of executed murderers13
to be used for anatomy studies “tends to keep up…the prejudice which is at present so
strong against the obtaining of bodies for dissection” (Lancet, 1824).
The situation has changed, slowly but profoundly.  In Britain, the Anatomy Act of 1832
considerably expanded the source of legal cadavers for dissection.  Today, the
“Bodyworlds” exhibits that have been touring museums worldwide feature partially
dissected cadavers in artful poses. Such exhibits do arouse some repugnance, although
not at the level that prevents the company from obtaining cadavers, or the shows from
attracting large audiences (<http://www.bodyworlds.com>; Barboza, 2006). There are
also today legal, regulated international markets for various storable transplantable
cadaver tissues (for example, bones), that can be used in surgical procedures such as hip
replacements (Mahoney, 2000). Opponents of regulated markets for organs will not be
reassured: there have been some notable abuses in the market for cadaver tissues,
including the widely publicized scandal (and subsequent prosecutions) associated with
the fraudulent sale of some of the body parts of Alistair Cooke, host of the television
show “Masterpiece Theater,” who died of cancer at the age of 95. Bone (2006) discusses
how the family authorization to harvest Cooke’s body parts was falsified, and so was
Cooke’s age and cause of death, thus interfering with medical decision-making on
appropriate use of body parts ( Howley, 2007).
Economists’ Voices in the Debate About Organ Sales
Sandel (2005) begins this way: “My topic tonight is ‘The Moral Limits of
Markets.’ My question is: Are there some things that should not be bought and sold, and,
if so, why?”  His talk was introduced by Stanley Hoffmann, who wrote: “The topic falls a
bit between the cracks of business school professors, who often hate to raise ethical
problems, and economists, who don’t always know what ethical problems are!” While
Hoffman’s jibe overstates the case, it does seem true that when confronted with
repugnance toward a market transaction, economists often respond as if a sufficiently
clear argument focused on the welfare gains due to trade will overcome that repugnance.
Becker and Elias in this issue present many of the arguments with which
economists and others often respond to concerns over the repugnance of paying live
kidney donors. The claim that organ sales “objectify” people is met by noting that in
labor markets generally, poorer workers tend to take more dangerous and less pleasant
jobs, in return for wages, and that we mostly think they do not diminish their humanity by
doing so. The response to arguments about “coercion” is typically that voluntary
transactions increase welfare of both the seller and the buyer, if the transaction is truly
voluntary. The response to “slippery slope” arguments is that markets can be regulated, if
necessary. Sometimes these arguments are supplemented by the observation that organ
donation itself could be criticized with some of the same objections made to organ sales,
even with a ban on monetary payments. For references to both sides of the debate,
particularly in the medical literature, see McCarrick and Darragh (2003) and Nadel and
Nadel (2005), and also Leonard (2004).14
In making such arguments, the role of repugnance per se is often regarded as a side issue.
For example, Radcliffe-Richards et al. (1998) conclude their “case for allowing kidney
sales” with the following statement:  “The weakness of the familiar arguments [against
kidney sales] suggests that they are attempts to justify the deep feelings of repugnance
which are the real driving force of prohibition, and feelings of repugnance among the rich
and healthy, no matter how strongly felt, cannot justify removing the only hope of the
destitute and dying. This is why we conclude that the issue should be considered again,
and with scrupulous impartiality.”
Some discussion has focused on thinking about how the worst abuses of unregulated
markets could be reduced by regulations. Such regulations might include: restrictions on
compensation (Gaston et al. 2006);  allowing outright purchases but only by a single
authorized governmental buyer (Satel, 2006); requiring an above-market-clearing price
(that might be bundled with insurance or annuities); mandatory standards for the health
and postoperative care of donors; or perhaps bans on international trade (since the
thought of rich Americans importing kidneys from the third world seems to arouse a
repugnance distinct from kidney sales itself).. Of course, the question of how much new
supply of kidneys would be elicited at what price is related both to whether the market
would be international, and to how how perceptions of repugnance (and not just of risk)
would influence the willingness to sell..
These arguments against banning organ sales leave many opponents unpersuaded.  For
example, Harmon and Delmonico (2006) write: “The Transplantation Society, the American
Society of Transplantation, the American Society of Transplant Surgeons, the European
Union, Eurotransplant, the National Kidney Foundation, the World Health Organization, and
more have long recognized the unethical realities regarding a regulated market, and each
organization has consistently opposed it.”
Readers who want to test their own potential repugnance to voluntary transactions by
well-informed, consenting adults might note that most of the arguments designed to
disarm repugnance to legalizing the sale of a kidney would also, in principle, apply to a
live donor who was willing to sell for a sufficiently high price an eye, an arm, a leg -- or a
heart.
Market Design When Repugnance Matters
My colleagues and I have encountered resistance to certain kinds of transactions when
helping design both markets that involve monetary transactions, like labor markets, and
allocation procedures that do not, like allocating public school places to children. Our
experience suggests that ideas about the inappropriateness of certain kinds of transaction,
even when this inappropriateness falls short of outright repugnance, can constrain market
design.
Many labor markets for entry-level professionals have suffered market failures due to
unraveling of the transaction times at which new employees are hired. Typically in these15
markets, the hiring date moves further and further in advance of employment, with firms
making potential employees “exploding offers” with the effect of not allowing employees the
opportunity to consider other opportunities before responding (Roth and Xing, 1994). This
kind of unraveling occurs in a variety of markets, from markets for new doctors and lawyers,
to markets for college football bowls. Often this leads to clearly inefficient outcomes;
Niederle and Roth (2003) show how this unraveling of appointment dates caused the markets
for new gastroenterologists to fragment from a national market into much more local
markets, and Frechette, Roth, and Unver (2007) show how the better matchups increase the
television viewership of bowl games. Sometimes there is an opportunity to correct such
market failures by creating clearinghouses that will provide a thick market (see for example
Roth 1984). Clearinghouses are also sometimes employed to fix market failures due to
congestion (Roth and Xing, 1997, Abdulkadiroglu, Pathak, and Roth, 2005).
When Muriel Niederle and I were asked to help implement a clearinghouse for the entry-
level market for gastroenterologists, along the lines of the medical match for new medical
graduates (Roth and Peranson, 1999), one issue was whether the gastroenterology
professional societies would adopt a resolution that would allow applicants who had accepted
early exploding offers, well before the date for the clearinghouse to operate, to subsequently
decline these offers and participate in the clearinghouse. Many gastroenterologists felt that it
would be unprofessional for future gastroenterologists to begin their careers by first
accepting an offer, and subsequently declining it.  But it was also widely felt that early
exploding offers were inappropriate and anti-competitive, and should be discouraged. After
much discussion, the four gastroenterology professional organizations became convinced that
allowing applicants to change their minds about exploding offers would make such offers
unprofitable, so that very few such offers would be made and subsequently declined.  This
prediction ultimately was fulfilled.  (Niederle, Proctor, and Roth 2006; Niederle and Roth
2006).  The relevance for the present essay is that much of the debate focused on the
propriety of how offers should be made, and accepted or rejected.
Discussions about propriety are not always decided on the basis of welfare. My colleagues
and I have encountered this at several junctures in designing public school choice allocation
procedures (for which monetary payments would be widely regarded as inappropriate).  In
Boston, one of the ways that children are assigned priority to enter particular schools is if
they have an older sibling already attending that school. We proposed two alternative designs
for a strategy proof allocation procedure, one of which was adopted (Abdulkadiro_lu, Pathak,
Roth, and Sönmez, 2005). The procedure that was rejected would have produced welfare
gains in cases in which two students each would have preferred to go to the school for which
the other had a high priority.  But this proposal was rejected because it would have allowed
the "trading" of sibling priorities, which was felt to be an inappropriate transaction, because
sibling priorities in particular shouldn’t be tradable, as they were assigned to families only to
make it easier for them to have both children in the same school if that was their preference.
Instead, Boston adopted a clearinghouse built along the lines of the clearinghouses designed
for medical matches, a modified version of which was also adapted for matching students to
high schools in New York City (Abulkadiro_lu, Pathak and Roth, 2005).16
This brings me back to kidney exchange.  My point in the present essay is simply that,
unlike the buying and selling of kidneys, in-kind exchanges have not aroused a repugnant
reaction.  The Roth et al. (2006) article reporting the success of a novel kind of exchange
in New England appeared, without any negative reaction, in the same issue of the
American Journal of Transplantation as the Gaston et al. (2006) proposal for modest
payments, and the Fox (2006) editorial reply that the proposal was repugnant. In fact,
legislation has passed Congress to amend the National Organ Transplant Act to explicitly
endorse kidney exchange:  the Living Kidney Organ Donation Clarification Act of 2007,
S. 487, passed in the Senate February 15, 2007 and H.R. 710 passed in the House of
Representatives on March 7, 2007, although the law has yet to be enacted..
Kidney exchange by itself won’t solve the general shortage of transplantable kidneys. In-
kind kidney exchange directly helps only people who already have a willing live donor
(although more complex kinds of exchanges can also directly help some patients on the
waiting list for a deceased-donor kidney, and every live donor transplant helps reduce the
demand for scarce deceased donor kidneys). However, if we can successfully organize
kidney exchange on a national scale, we might be able to do several thousand more
transplants per year (instead of the dozens to which the local and regional exchanges are
still presently limited). The increase would come both from extending the possibility of
exchange to all regions of the country, and from the increasing number of exchanges that
result when there is a thicker market consisting of more available patient-donor pairs.
Whatever other policies might be adopted in the more distant future to benefit patients
who need transplants, or to reduce the incidence of kidney disease, kidney exchange
offers real gains that have proved to be achievable.
Conclusions
Repugnance can be a real constraint on markets. Almost whenever I have been involved in
practical market design, the question of whether certain kinds of transactions may be
inappropriate has come up for discussion.
5
To say that repugnance is a real phenomenon doesn’t mean that repugnance isn’t sometimes
deployed for strategic purposes by self-interested parties, to recruit allies who would not
respond to a clear appeal to narrower motives such as rent seeking. The opposition of
insurance companies to viatical settlements might be an example. Experiments in the
laboratory show clearly how arguments about unfairness can be deployed in a self-interested
way, with agents’ perception of what is fair closely correlated with their interests (for
example, Roth and Murnighan, 1982).  But the real repugnance that some people feel toward
some transactions means that economists interested in proposing and designing markets must
take this repugnance into account.
                                                   
5 One notable exception has been in my role as chair of the American Economic Association’s, Ad Hoc
Committee on the Job Market, which has implemented several changes in the market for new Ph.D.
economists. As nearly as I can recall, our discussions have focused only on efficiency and incentives. (The
other members of that committee are John Cawley, Philip Levine, Muriel Niederle, and John Siegfried.)17
The debate over whether the sale of kidneys should be legalized is just one example among
many in which repugnance plays a large role.  Because of its importance, the arguments on
both sides have been presented with particular force and clarity.  All parties agree it is
urgently desirable to cure patients with end stage renal disease, and that the best current
treatment is organ transplantation, particularly from live donors.  The current situation in the
United States involves long wait times for deceased donor kidneys by tens of thousands of
patients without a live donor, difficult and costly palliative treatment by dialysis, and
thousands of deaths annually while waiting.  But opponents of organ sales find the prospect
of a market for organs so repugnant as to be worse than the current situation. Proponents of
markets are correspondingly frustrated at the failure to adopt what they see as a feasible
solution that could be implemented quickly.
One way of seeing the role that repugnance plays in this debate is to compare it to a difficult
technological barrier.  If the technological barriers could be overcome that currently prevent,
say, transplanting pig kidneys into human patients, such “xenotransplants” would also end
the kidney shortage.  But no one supposes that this solution can be implemented quickly,
because some technological barriers cannot be overcome quickly, if at all. I’ve argued in this
essay that repugnance is similar to technological barriers in this respect: markets that we can
envision may nevertheless not be easily achievable. I would not like to guess whether repeal
of the widespread laws against kidney sales is likely to happen more quickly than the
advances in xenotranplantation, or artificial kidneys, or other medical breakthroughs that
would end the shortage of kidneys.
Of course, there can also be “technological” developments in the law. For example, Volokh
(2007) endorses a “medical right to self defense,” that would give a person dying of end
stage renal disease the right to pursue all reasonable avenues to preserve their life, including
purchasing a kidney. If this argument or one like it makes headway, the courts might end
bans on organ sales. Popular repugnance often affects courts differently than legislatures; for
example, the ban on gay marriage was lifted in Massachusetts by a court interpreting the state
constitution’s guarantee of equal protection, not by new legislation. The Massachusetts court
decision is an example in which a ban based on a repugnance that had survived since at least
Biblical antiquity was ended quite suddenly, although repugnance-inspired political battles
on the issue continue.
The persistence of repugnance in many markets doesn’t mean that economists should give up
on the important educational role of pointing to inefficiencies and tradeoffs and costs and
benefits.  But neither should economists expect such arguments to immediately win every
debate. Being aware of the sources of repugnance can only help make such discussions more
productive, not least because it can help separate the issues that are fundamentally
empirical—like the degree of crowding out of altruistic donations that might result from
different incentive schemes compared to how much new supply might be produced—from
areas of disagreement that are not primarily empirical.
Just as economists and other proponents of legalizing kidney sales may not always take
repugnance with sufficient seriousness, opponents of such sales often fail to directly
address the costs of the current kidney shortage, borne directly by kidney patients, and18
indirectly by society as a whole. Although economists see very few tradeoffs as
completely taboo, non-economists often decline to discuss tradeoffs at all, preferring to
focus on the repugnance of transactions like organ sales.  Advocates of well regulated
markets for organ transplants could more clearly address the concern that markets are
hard to regulate perfectly and that at least some repugnant transactions would likely slip
through even the best regulatory barriers . Opponents could better engage the question of
why a carefully regulated market with some inevitable abuses might not possibly,
nevertheless, be an improvement over current conditions. (In this view, the current
situation can be viewed as a regulated market with the only legal price being zero, which
makes it difficult to prevent unregulated transactions on international black markets, see
e.g. the account in Morais, 2007).
Discussion itself may change some views on repugnance (Baron and Leshner, 2000), in some
cases by reducing visceral repugnance, and in others by refining it.  A participant in the
discussion of a draft of this paper by the Chicago Transplant Ethics Consortium (personal
communication, Jason Snyder, 1/29/2007) noted: “I think that the visceral response that
almost everyone has to the notion of a market for organs, what they feel the first 10 seconds
after hearing about such a market, is a significant sense of repugnance. According to [the
previous discussion,] a few years ago most people in the transplant community felt this way.
However it appears that there is a growing divergence of opinion on this topic in the
transplant community. Essentially what I think is happening is that the more people carefully
think about these issues, the more they get beyond the initial yuck factor. Some go towards
the pro-market side, and others stay on the anti-market side for reasons that go deeper than
the first visceral response."
No one can contemplate the costs to the sick and dying without sharing the concern for a
solution to the shortage of transplantable organs.  The questions are, what kinds of solution
are feasible and desirable, how to get from here to there, on what time scale, with what costs,
to whom, and what to do in the meantime?19
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Table 1
Markets In Which Some Transactions Are, or Were Once, Repugnant
Human Remains
Cadavers for anatomical study, organ donation, bone and tissue
Live donor organs (kidneys, livers)
Labor
Indentured servitude, slavery
Volunteer army, mercenary soldiers
Discrimination on race, gender, handicap, marital status, etc.
Reproduction and sex
Adoption
Surrogate mothers, egg and sperm donation, abortion, birth control
Prostitution, pornography
Bride price, dowry
Polygamy, gay marriage, incest
Words, ideas, and art
Obscenity, profanity, and blasphemy
Cultural treasures, art, and antiquities
Risk
Life insurance for adults, children, and strangers
Gambling
Prediction markets
Finance
Short selling, currency speculation
Interest on loans
Pollution markets:
Tradeable emissions entitlements
Dirty industries in less developed countries
“Price gouging”
After natural disasters
Ticket scalping
Religion/Sports
Sale of indulgences, ecclesiastical offices, etc. (“simony”)
Endorsements/payments for amateur versus pro athletes
Drugs and sports21
Food, drink, and drugs
Horse and dog meat
Alcohol (Prohibition)
Marijuana and narcotics
Vote selling and Bribery
Dwarf-tossing22
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